Isolated metastatic lesion of hyoid bone in gastric cancer: A rare case
- Authors: Ognerubov N.A.1, Antipova T.S.2
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- PET-Technology
- Issue: Vol 27, No 1 (2025)
- Pages: 32-35
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/291145
- DOI: https://doi.org/10.26442/18151434.2025.1.203198
- ID: 291145
Cite item
Full Text
Abstract
Background. Secondary hyoid tumors are extremely rare. There are few documented reports of metastases into hyoid in patients with distant localizations of malignancies, such as breast, lung, kidney, liver, and sigmoid colon cancers. The article describes a rare case of metastases of advanced gastric cancer to the hyoid bone.
Aim. To present a clinical case of isolated metastatic lesion of the hyoid bone in a patient with primary advanced gastric cancer, demonstrating the possibility of increasing the duration and quality of life using polychemotherapy.
Results. A 54-year-old male with synchronous pain in the throat and epigastrium when swallowing solid food and weight loss underwent esophagogastroduodenoscopy, which showed a defect in the mucosa along a small curvature in the middle third of the stomach. Histological examination showed colloid cancer. Combined positron-emission and X-ray computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) revealed a gastric tumor with radiopharmaceutical hyper uptake, serous membrane invasion and involvement of paragastric, celiac, retroperitoneal, and mediastinal lymph nodes. The entire hyoid bone was swollen with fragmentary cortex destruction. Stage IV gastric cancer cT4bN3аM1 was diagnosed with metastases to the hyoid bone, mediastinal, and retroperitoneal lymph nodes. The patient received eight cycles of polychemotherapy with the XELOX regimen and reported the resolution of sore throat and epigastric pain. The results of PET/CT with 18F-FDG showed sclerosis of the cortical layer of the hyoid bone and no abnormal radiopharmaceutical uptake. The patient has been alive for 13 months.
Conclusion. Hypoglossal bone metastases are extremely rare in patients with advanced colloid cancer. Such case was described for the first time. The method of choice for diagnosing and assessing the extent of the tumor is PET/CT with 18F-FDG. Palliative polychemotherapy can increase the duration and improve the quality of life.
Full Text
##article.viewOnOriginalSite##About the authors
Nikolai A. Ognerubov
Russian Medical Academy of Continuous Professional Education
Author for correspondence.
Email: ognerubov_n.a@mail.ru
ORCID iD: 0000-0003-4045-1247
D. Sci. (Med.), D. Sci. (Law), Prof.
Russian Federation, MoscowTatiana S. Antipova
PET-Technology
Email: ognerubov_n.a@mail.ru
ORCID iD: 0000-0003-4165-8397
Radiologist
Russian Federation, MoscowReferences
- Rivera-Serrano CM, Branstetter BF 4th, Johnson JT. Osteoblastoma of the hyoid bone. AJNR Am J Neuroradiol. 2010;31(6):1080-1. doi: 10.3174/ajnr.A1872
- Zhang YH, He YF, Yue H, et al. Solitary hyoid plasmacytoma with unicentric Castleman disease: A case report and review of literature. World J Clin Cases. 2022;10(36):13364-72. doi: 10.12998/wjcc.v10.i36.13364
- Kusama H, Okishiro M, Ishida T, et al. A case of hyoid bone metastasis from breast cancer. Gan Kagaku Ryoho. 2014;41:1915-7.
- Iguchi H, Okabe Y, Takayama M, et al. Solitary hyoid bone metastasis from hepatocellular carcinoma treated with surgery. Nihon Jibiinkoka Gakkai Kaiho. 2012;115(8):783-6. doi: 10.3950/jibiinkoka.115.783
- Passah A, Agarwal KK, ArunRaj ST, et al. A rare site of hyoid bone metastasis in patients with renal cell carcinoma on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan. Indian J Nucl Med. 2016;31(4):319. doi: 10.4103/0972-3919.190806
- Aljariri AA, Nashwan AJ, Hammoud R, et al. Metastatic sigmoid adenocarcinoma to the larynx: A case report and updated literature review. Clin Case Rep. 2023;11:e6942.
- Di Marco GP, Tucci C, Iacomino E, et al. Hyoid Bone Metastases: An Unusual Case. Reports. 2023;6:59. doi: 10.3390/reports6040059
- Ryan JF, Xie DX, Eytan DF, et al. Melanoma metastatic to the hyoid bone. Clin Case Rep. 2020;9(1):522-5. doi: 10.1002/ccr3.3571
- Lee HS, Lee JH, Kim SW, Lee KD. Metastatic renal cell carcinoma to the hyoid bone. Otolaryngol Head Neck Surg. 2010;142(6):913-4. doi: 10.1016/j.otohns.2010.01.002
- Zhang HY, Shan Li S, Guo X, et al. Hyoid Bone Metastasis in Patients With Lung Adenocarcinoma: A Case Report. Ear, Nose Throat J. 2020;014556132091698. doi: 10.1177/0145561320916985
- Bracanovic D, Vukovic V, Janovic A, et al. Hyoid Bone and Thyroid Cartilage Metastases from Sigmoid Colon Adenocarcinoma: A Case Report. Balkan Med J. 2017;34(3):278-80. doi: 10.4274/balkanmedj.2015.1817
- Hsu J, Hribar K, Poen J. Radiotherapy for hyoid bone metastasis from lung adenocarcinoma: A case report. World J Clin Oncol. 2024;15(1):159-64. doi: 10.5306/wjco.v15.i1.159
- Timon CI, Gullane PJ, Brown D, Van Nostrand AW. Hyoid bone involvement by squamous cell carcinoma: clinical and pathological features. Laryngoscope. 1992;102(5):515-20. doi: 10.1288/00005537-199205000-00008
- Fujita I, Toyokawa T, Makino T, et al. Small early gastric cancer with synchronous bone metastasis: A case report. Mol Clin Oncol. 2020;12:202-7. doi: 10.3892/mco.2020.1985
- Ameur WB, Belghali S, Akkari I, et al. Bone metastasis as the first sign of gastric cancer. Pan Afr Med J. 2017;28:95. doi: 10.11604/pamj.2017.28.95.13787
- Dassen AE, Lips DJ, Hoekstra CJ, et al. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35(5):449-55. doi: 10.1016/j.ejso.2008.11.010
- Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. Available at: https://gco.iarc.who.int/today/ Accessed: 02.02.2024.
- Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg. 1983;13:173-6.
- Park JM, Song KY, O JH, et al. Bone recurrence after curative resection of gastric cancer. Gastric Cancer. 2013;16(3):362-9. doi: 10.1007/s10120-012-0193-y
- Kobayashi M, Okabayashi T, Sano T, Araki K. Metastatic bone cancer as a recurrence of early gastric cancer -- characteristics and possible mechanisms. World J Gastroenterol. 2005;11(36):5587-91. doi: 10.3748/wjg.v11.i36.5587
- Kang SH, Kim JI, Moon HS, et al. Overt bone marrow metastasis from early gastric cancer. Endoscopy. 2008;40 Suppl. 2:E34-5. doi: 10.1055/s-2007-966860
- Ma DW, Kim JH, Jeon TJ, et al. ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer. Dig Liver Dis. 2013;45(9):769-75. doi: 10.1016/j.dld.2013.02.009
- Kawanaka Y, Kitajima K, Fukushima K, et al. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. Eur J Radiol. 2016;85(5):989-95. doi: 10.1016/j.ejrad.2016.03.003
- Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4
- Shitara K, Takashima A, Fujitani K, et al. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Lancet Gastroenterol Hepatol. 2017;2(4):277-87. doi: 10.1016/S2468-1253(16)30219-9
Supplementary files
